THE DEVELOPMENT OF ANTHRACYCLINE ANALOGS (REVIEW)

  • Authors:
    • PA VASEY
  • View Affiliations

  • Published online on: April 1, 1993     https://doi.org/10.3892/ijo.2.4.677
  • Pages: 677-681
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The anthracycline class of antitumour agents have the widest spectrum of activity of all drugs used to treat malignant disease. Consequently they are ubiquitous in their use worldwide, but are not without problems. The abrogation of cardiac toxicity and the development of drug resistance has been attempted by modifying the molecule chemically, producing over 1000 structural analogues since the discovery of Daunorubicin in the late 1950's. This review charts this developmental process and points to the possible future of this important class of drugs.

Related Articles

Journal Cover

April 1993
Volume 2 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
VASEY P: THE DEVELOPMENT OF ANTHRACYCLINE ANALOGS (REVIEW). Int J Oncol 2: 677-681, 1993
APA
VASEY, P. (1993). THE DEVELOPMENT OF ANTHRACYCLINE ANALOGS (REVIEW). International Journal of Oncology, 2, 677-681. https://doi.org/10.3892/ijo.2.4.677
MLA
VASEY, P."THE DEVELOPMENT OF ANTHRACYCLINE ANALOGS (REVIEW)". International Journal of Oncology 2.4 (1993): 677-681.
Chicago
VASEY, P."THE DEVELOPMENT OF ANTHRACYCLINE ANALOGS (REVIEW)". International Journal of Oncology 2, no. 4 (1993): 677-681. https://doi.org/10.3892/ijo.2.4.677